Skip to Content
Søk Menu
8.-16. JUNI 2023

Følg med når vi dekker EHA 2023 l European Hematology Association’s Annual Congress

Høydepunkter EHA 2022

Phase 1 Results in SIRPα Antibody CC-95251 in Combination with Rituximab in Patients with R/R NHL

  • / Paolo Strati

Othman Al-sawaf

CLL14 study five-year results: Significantly superior efficacy for Ven-Obi

/ Othman Al-sawaf
EHA22CLL Play the Video
Jakob Nordberg Nørgaard

Carfilzomib-lenalidomide-dexamethasone konsolidering i myelomatosepasienter

/ Jakob Nordberg Nørgaard
MyelomatoseEHA22 Play the Video
Paul Richardson

Treatment with RVD + stem cell transplant achieved higher PFS vs RV alone In patients with newly diagnosed multiple myeloma

/ Paul G. Richardson
MyelomatoseEHA22 Play the Video
Jean-Marie Michot

Novel oral agent with promising result as second-line treatment option for patients with T-Cell Lymphoma

/ Jean-Marie Michot
LymfomEHA22 Play the Video
Paul Richardson

A new randomized study suggests an improved depth of response and PFS for patients relapsing on Lenalidomide

/ Paul G. Richardson
MyelomatoseEHA22 Play the Video
Arnon Kater

The main clinical message from the Five-Year Analysis of Murano Study

/ Arnon P. Kater
EHA22CLL Play the Video
Paul Richardson

Longer PFS and higher ORR for frailty patients with R/R Multiple Myeloma treated with PVd than Vd

/ Paul G. Richardson
MyelomatoseEHA22 Play the Video
Jakob Nordberg Nørgaard

A new study shows that PTCD and MRD are complementary and necessary for doing a whole assessment on patient-response for myeloma patients

/ Jakob Nordberg Nørgaard
MyelomatoseEHA22 Play the Video
Carsten Utoft Niemann

This is what Carsten Niemann concludes from the recent CLL studies

/ Carsten Utoft Niemann
EHA22CLL Play the Video
Jean-Marie Michot

Manageable safety profile and promising efficacy in heavily pretreated patients with R/R Non-Hodgin Lymphoma

/ Jean-Marie Michot
LymfomEHA22 Play the Video
Load more

Gå ikke glipp av de siste nyhetene fra Hematologi

Registrer deg og få nye artikler, MEDtalks og tidsskrifter direkte til din innboks

Få adgang

Høydepunkter innenfor onkologi-hematologi

Significant improvements in OS and RFS for older patients with AML

/ Farhad Ravandi
AMLEHA21 Play the Video

Iberdomide show promising efficacy in heavily pretreated patients with Relapsed/Refractory Multiple Myeloma

/ Sagar Lonial
MyelomatoseEHA21 Play the Video

Highlights EHA 2021 (2:2)

/ Agoston Gyula Szabos
EHA21 Play the Video

Highlights EHA 2021 (1:2)

/ Agoston Gyula Szabos / Fredrik Schjesvold
EHA21 Play the Video

EHA-ESMO Clinical Practice Guidelines for Multiple Myeloma

/ Fredrik Schjesvold
MyelomatoseEHA21 Play the Video

Potential to become the best treatment for multiple myeloma in history

/ Thierry Facon
MyelomatoseEHA21 Play the Video

New bispecific antibody with promising efficacy and safety profil for patients with relapsed/refractory Multiple Myeloma

/ Amrita Y. Krishnan
MyelomatoseEHA21 Play the Video

First-in-human study of teclistamab for relapsed/refractory Multiple Myeloma

/ Niels van de Donk
MyelomatoseEHA21 Play the Video
Load more

Back to top